Incyte News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.01.17	Incyte And Calithera Collaborate To Develop And Commercialize CB-1158 (RTTNews)
17.01.17	FDA Delays Decision On Lilly's Rheumatoid Arthritis Drug Candidate (RTTNews)
13.01.17	U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment (PR Newswire)
09.01.17	Incyte & Merck Expand Clinical Trial On Combination Of Epacadostat With KEYTRUDA (RTTNews)
29.12.16	Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma (PR Newswire)
29.12.16	Biotech Stocks Facing FDA Decision In January (RTTNews)
16.12.16	CHMP Recommends Approval Of Lilly's Baricitinib For Rheumatoid Arthritis (RTTNews)
16.12.16	CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA) (PR Newswire)
14.11.16	Lilly Says New Analyses Of Phase 3 Trials Show Improvements In RA Symptom (RTTNews)
01.11.16	EARNINGS SUMMARY: Details of Incyte Corporation Q3 Earnings Report (RTTNews)
01.11.16	Incyte Corp. Updates 2016 Guidance - Quick Facts (RTTNews)
27.09.16	Incyte : NCCN Guidelines Recommend Jakafi For Treatment Of Myelofibrosis (RTTNews)
09.08.16	Incyte Corporation Q2 Earnings Climb 271% (RTTNews)
23.06.16	Incyte: Ruxolitinib Receives Breakthrough Therapy Designation - Quick Facts (RTTNews)
23.06.16	NYMX Grabs Headlines, MRNS Awaits Data In 2H, PSTI Takes Small Step In DMD Race (RTTNews)
09.06.16	Lilly : Baricitinib Reduces Joint Damage Progression In Rheumatoid Arthritis (RTTNews)
09.05.16	Incyte To Acquire ARIAD's European Operations, In-license Iclusig In Europe (RTTNews)
09.05.16	EARNINGS SUMMARY: Details of Incyte Corporation Q1 Earnings Report (RTTNews)
07.04.16	BIND In A Fix, APRI To File NDA In Q3, TSRO Abuzz (RTTNews)
06.04.16	Incyte Acquires Rights To Ruxolitinib From Eli Lilly - Quick Facts (RTTNews)
24.03.16	Aduro : First Patient Dosed In CRS-207-Epacadostat Trial To Treat Ovarian Cancer (RTTNews)
12.02.16	AEGR Lays Off 25% Staff, INCY Discontinues Ruxolitinib Trials, ZBH Gets FDA Nod (RTTNews)
11.02.16	Incyte Expects 2016 Jakafi Product Revenues Of $800-$815 Mln - Quick Facts (RTTNews)
11.02.16	EARNINGS SUMMARY: Details of Incyte Corporation Q4 Earnings Report (RTTNews)
11.02.16	Incyte To Discontinue JANUS Studies Of Ruxolitinib Plus Capecitabine (RTTNews)
19.01.16	Lilly Submits NDA To FDA For Oral Once-Daily Baricitinib; Backs FY16 EPS View (RTTNews)
03.11.15	Incyte Announces Presentation Of Findings From Phase 1/2 Study On Epacadostat (RTTNews)
03.11.15	EARNINGS SUMMARY: Details of Incyte Corporation Q3 Earnings Report (RTTNews)
15.10.15	Shareholder Ups Stake In AFMD, Sweet Tidings From DXCM, PFE Snubbed, LLY Beams (RTTNews)
13.10.15	Incyte, Merck To Initiate Phase 3 Study For Epacadostat, Keytruda Combination (RTTNews)
02.09.15	Incyte In Global License Deal For SHR-1210; To Make Upfront Payment Of $25 Mln (RTTNews)
04.08.15	Incyte Turns To Profit In Q2 - Quick Facts (RTTNews)
04.08.15	EARNINGS SUMMARY: Details of Incyte Corporation Q2 Earnings Report (RTTNews)
07.07.15	Incyte,Vanderbilt University Medical Center Establish Oncology Research Alliance (RTTNews)
19.06.15	Incyte Forms Two New Units; Announces Management Changes - Quick Facts (RTTNews)
01.06.15	Advaxis Announces FDA Clearance Of IND Application For Phase 2 Study Of ADXS-HPV (RTTNews)
30.04.15	Incyte Q1 Loss Narrows - Quick Facts (RTTNews)
24.02.15	BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back (RTTNews)
12.02.15	Incyte Q4 Loss Narrows - Quick Facts (RTTNews)
09.01.15	Incyte, Agenus Report Alliance To Develop Novel Immuno-Oncology Antibodies (RTTNews)
09.12.14	Eli Lilly, Incyte Say Arthritis Drug Baricitinib Meets Primary Endpoint (RTTNews)
05.12.14	CLRB Spikes Over 13%, OVAS In Good Health, INCY, MYL Get FDA Nod (RTTNews)
04.12.14	Incyte: FDA Oks Jakafi To Treat Uncontrolled Polycythemia Vera (RTTNews)
30.10.14	Incyte Turns To Profit In Q3, Results Beat Estimates; Raises FY Revenue Guidance (RTTNews)
17.10.14	Incyte Appoints David Gryska As CFO - Quick Facts (RTTNews)
02.10.14	Incyte Earns $60 Mln Milestone On Reimbursement Of Jakavi In Europe (RTTNews)
06.08.14	GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date (RTTNews)
31.07.14	Incyte Q2 Loss Widens, Boosts 2014 Outlook - Quick Facts (RTTNews)
08.07.14	Incyte Earns $25 Mln Milestone Payment From Novartis On Jakavi Approval In Japan (RTTNews)
03.06.14	AQXP Goes Sprinting, ARGS On Watch, BIOC Adds New Product, An Insight On RECAP (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

18:01		Gewinne in New York: S&P 500 legt mittags zu
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
19.11.24		Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen
19.11.24		Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen
19.11.24		Verluste in New York: S&P 500 startet im Minus
29.10.24		Börse New York in Grün: S&P 500 beendet die Sitzung im Plus
29.10.24		Börse New York: S&P 500 fester
29.10.24		Optimismus in New York: So bewegt sich der S&P 500 am Mittag

18:01

Gewinne in New York: S&P 500 legt mittags zu

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

19.11.24

Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen

19.11.24

Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen

19.11.24

Verluste in New York: S&P 500 startet im Minus

29.10.24

Börse New York in Grün: S&P 500 beendet die Sitzung im Plus

29.10.24

Börse New York: S&P 500 fester

29.10.24

Optimismus in New York: So bewegt sich der S&P 500 am Mittag

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	74.04	2.41 %	K V
ABB	52.12	1.68 %	K V
Geberit	552.80	1.32 %	K V
Alcon	78.04	1.19 %	K V
CieFinRichemont	129.05	1.10 %	K V
Swiss Life Hldg	686.00	-0.64 %	K V
Zurich Insur Gr	555.20	-1.00 %	K V
Holcim	90.66	-1.31 %	K V
Kuehne+Nagel Int	210.60	-1.31 %	K V
Novartis	90.10	-3.14 %	K V

Nachrichten zu Incyte Corp.

Aktien Top/Flop

Incyte Peer Group Nachrichten

Meistgelesene Nachrichten